Hydrocephalus is a common and serious complication of aneurysmal subarachnoid hemorrhage (aSAH), occurring in approximately 20–30% of patients. It results from impaired cerebrospinal fluid (CSF) circulation and absorption due to blood products within the subarachnoid space and ventricular system.
Hydrocephalus complicates the clinical course of greater than 20% of patients with aneurysmal subarachnoid hemorrhage 1) 2) , and its onset can be acute, within 48 hours after SAH, or rarely chronic, occurring in a delayed fashion weeks and even months after the hemorrhage 3).